Shenzhen Weiguang Biological Products Co., Ltd.
SHZ: 002880.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Caiping Guo
- Employees
- 859
- Headquarters
- Shenzhen, China
- IPO year
- 2017
- Market cap
- CN¥5.8B
- Website
- https://www.szwg.com
Loading 002880…
Loading profile data…Frequently asked questions about 002880
What does Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) do?
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglob...
Where does 002880.SZ trade?
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002880.SZ in?
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Weiguang Biological Products Co., Ltd.?
Caiping Guo is the chief executive officer of Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ).
Where is Shenzhen Weiguang Biological Products Co., Ltd. headquartered?
Shenzhen Weiguang Biological Products Co., Ltd. is headquartered in China.
Does 002880.SZ pay a dividend?
Yes — Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) paid a trailing twelve-month dividend of CNY 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002880.SZ go public?
Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ) completed its initial public offering in 2017.